GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Other Operating Expense

Hamlet BioPharma AB publ (XSAT:HAMLET B) Other Operating Expense : kr48.71 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Other Operating Expense?

Hamlet BioPharma AB publ's Other Operating Expense for the three months ended in Mar. 2025 was kr12.49 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr48.71 Mil.

Hamlet BioPharma AB publ's quarterly Other Operating Expense increased from Sep. 2024 (kr10.44 Mil) to Dec. 2024 (kr13.98 Mil) but then declined from Dec. 2024 (kr13.98 Mil) to Mar. 2025 (kr12.49 Mil).

Hamlet BioPharma AB publ's annual Other Operating Expense increased from Jun. 2022 (kr17.12 Mil) to Jun. 2023 (kr20.54 Mil) and increased from Jun. 2023 (kr20.54 Mil) to Jun. 2024 (kr42.53 Mil).


Hamlet BioPharma AB publ Other Operating Expense Historical Data

The historical data trend for Hamlet BioPharma AB publ's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Other Operating Expense Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.85 -5.16 17.12 20.54 42.53

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.48 11.80 10.44 13.98 12.49

Hamlet BioPharma AB publ Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr48.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines